Back to 
Woodline Partners LP
Woodline Partners LP
AKBA
Showing 3 of 13 quarters
Position history for Woodline Partners LP's holdings in AKEBIA THERAPEUTICS INC
No. Woodline Partners exited its AKBA (Akebia Therapeutics) position in Q3 2025. Its Q2 2025 13F listed 1,001,360 shares worth $3.6M. Woodline Partners already held AKBA in its Q4 2019 13F, the earliest on record, and held it in 10 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$4.8M
Total Shares Change
-2.5M
Quarter-by-Quarter History